API
< Back to all clusters
[HEALTH] · Poland · 2 sources

started · updated

Weight loss medications and habit formation for fat reduction

Weight loss injections such as Ozempic, Wegovy, and Mounjaro work by mimicking intestinal hormones to reduce appetite and increase satiety. While Wegovy and Ozempic utilize semaglutide, Mounjaro uses tirzepatide, which targets two hormones and may result in greater average weight loss. These medications are intended for treating obesity in adults with a BMI of at least 30, or 27 if accompanied by weight-related conditions like hypertension or sleep apnea.

In Poland, these treatments are not reimbursed for obesity, with monthly costs ranging from several hundred to nearly 2,000 PLN. Experts emphasize that pharmacotherapy requires medical supervision and a long-term approach rather than being a quick fix.

Beyond medication, sustainable fat loss relies on maintaining a caloric deficit through lifestyle habits. Research suggests that establishing new habits typically takes between 66 days and several months, rather than the commonly cited 21 days. Key factors for success include increasing non-exercise activity thermogenesis (NEAT), ensuring adequate protein intake, and prioritizing sleep to manage appetite.

Entities

Mounjaro · Ozempic · Polish Obesity Treatment Society · University College London · Wegovy